Takeda is buying Adderall maker Shire for $64 billion in pharma’s biggest deal of the year
|04/25/2018||Posted by BusinessMediaguide.Com under General World News||
- Takeda has reached a deal to buy Adderall drugmaker Shire for $64.3 billion.
- The deal comes after a handful of rejections from Shire and a short-lived potential for a bidding war between Takeda and Botox-maker Allergan.
- A transaction between Shire and Takeda is the largest pharma deal of the year.
Takeda has reached a preliminary agreement to buy Adderall drugmaker Shire for $64 billion in the largest pharma deal of the year.
The deal strengthens the Japanese drugmakers’ footprint in the US, where Shire has a large presence, and also expands its position in rare diseases like hemophilia.
Takeda, read more >>>